Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hear ya on the bonds. I almost went that direction a year ago. I’m waiting for NRGU to go below $300/share and buy back in. But with the election this year I’m standing firm. 2025 I’ll re-evaluate my investments.
Put a cool MM into a 3 or 6 month t bill. 100,000$ over a year.
T Bills are the way to go now
T Bills are near 5.45%. Sell and put into a 5 month T Bill.
Ok, I still may be one of the earliest investors at 1999. Feeling as you do, SGolfer, the money is spent and no worries if I lose it all. The upside, I feel, is greater than the downside. Good luck to all, including those that have lost patience with Mr Chan. Hang in there! Better times just around the corner.
Wow! 1995! I thought I was one of the earliest investors at 1999. Way to stick with it.
My concern is we lose our current leading edge technology to another startup who finds a better solution to diabetes care before ours hits the market. I long forgot about the dollars invested, my enthusiasm is waning. I rarely check on ALRTF. That’s sad to me.
Thanks for sharing, Rdizz. I’m not sure how much money I’ve invested, the highest pps was around $2.50 back in 1999. Been buy a little extra when I had fun money but am now on a retirement budget and can’t afford extra cost. My total holdings are at 120,000 shares. I could use money to help pay down my new home build but not confident that happens this year. My pipe dream is $3-$5/share. Not sure that can happen. Best wishes all
Just wondering, all you peeps invested in ALRTF, how much money are you into this? At $0.05 you’re probably under $50M and most of you are prob under $10M. I’ve been around the longest, paid the highest price per share and been averaging down over the years. I have no complaints. It was fun money, not rent money. I’m enjoying this ride. If it fails, no worries, I’ll be ok. I’ve brought others into it and have fun joking about the daily dive in share price. Creating memories and great stories. My family laughs at me and my dream of big returns. How will you be when it fails? I hope you all can laugh at the end rather than cry. Best wishes to all. Happy Easter. He is Risen! Alleluia! Alleluia!
285,000 shares traded today. Seems like a high number. Anything going on?
Yep, got most of them, thanks. And big props to jammaster for the update.
Put a buy in for 25k at the ask. Fingers crossed.
Didn’t realize there were so many players in the market. Still, I’ll continue to average down my losses by purchasing more shares at $0.03 and the hope of selling some shares when it hits $12.50/share.
COMPETITION ANALYSIS
Competitive analysis and profiles of the major players in the pet diabetes care devices, such as AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc. are provided in this report. There are some important players in the market such as AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company. Various players have adopted strategies like partnership, and acquisition as key developmental strategies to improve the product portfolio of the pet diabetes care devices market.
Partnership in the market
In June 2022, ALRT, the diabetes management company, announced the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd. to manufacture and supply the Continuous Glucose Monitor (“CGM”) hardware that is utilized as a part of the ALRT GluCurve Pet CGM. This agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply.
In December 2022, ALRT, the diabetes management company, announced its co-branded distribution agreement with Covetrus, Inc., a global leader in animal-health technology and services, for ALRT's GluCurve Pet CGM, a continuous glucose monitoring (“CGM”) system for diabetic cats and dogs.
Picked up some groceries to make cheesesteaks at lunch. $49.00! $10 for 12oz of shaved ribeye. Can’t even make it an even pound, for crying out loud. And the gov says the economy is booming. Yeah, right! Just not for the little guy.
At $16.00/share I’ll sell half my bag. Otherwise this becomes part of my estate and the wife would dump it for a free bag of groceries. In the current economics, that’s not far off its true value.
Glad you found it helpful. 23+ years and still patiently waiting.
Found this nugget today.
Low flower $ALRTF ($0.03) launching Pet CGM in Canada Aug 28th with $700,000 sale value for first order
$ALRTF has a float of 163,000,000 and trades on the higher OTC.QB tier which means they are fully SEC reporting. The CEO and his family basically own the rest of the O/S with restricted shares so he doesnt make money unless we shareholders make money. No toxic dilution in the history of the company.
Today they just announced they are starting sales for their one of a kind pet CGM for diabetic dogs and cats in Canada on August 28th, their initial purchase order of inventory carries a sales value of $600k-$700k. ALRT also partnered with a company called Covetrus who was just bought out and taken private for $4 billion, the PR mentions that they up upgrading to an even newer model CGM and will relaunch with Covetrus in the US and EU in Q4.
Regarding the product itself, diabetic dogs and cats can't be monitored like humans because you can't prick their fingers with a lancet to test. You can only draw blood from a vein in their ear/paw with a lancet and it is very difficult to do. To monitor their diabetes they get dropped off at a vet clinic for 12 hours and the vet draws blood with a needed every 2 hours to make a glucose curve graph that shows how their blood sugar is doing over the 12 hour course of insulin.
Since that method delivers so few readings, inaccuracies from stress, and is costly, instead veterinarians have been prescribing the human CGM Libre 2 to monitor diabetes in pets. But because it requires a prescription vets cant make money off it and the pet owner has to make a 2nd appointment to come back and have it applied. Also the company that makes Libre does not support it for animal use and there are tons of problems with the hardware and software.
That being said, I am very confident the GluCurve Pet CGM will be a huge success, according to ALRT there are 75,000+ diabetic dogs and cats in Canada, nearly 1 million in the USA, and nearly 1 million in the EU. The market is huge and the market is desperate for a solution.
Yes, volume is very low but that will change very soon in my opinion. Also, you have to use a real broker to buy/sell shares of ALRTF its not available on robinhood.
Although CGM is important to diabetes care the thing that separates ALRTF from all others is the value added feature (patented, internationally protected) Predictive A1C. Are we too focused on CGM and losing sight of the real prize?
Patience please. The finish line is in sight. Be the tortoise, not the hare.
I picked up some shares under $0.04 during this down turn. Averaging down my $2+/share initial investment. Hoping this rollercoaster ride continues a bit longer. Probably have less than 20 years left. Holding out hope this pays off before the end. Good luck, all!
Where is the significant rise in sales? Where are we with the human side of CGM/Predictive A1C?
I expected an update the beginning of April. That ship sailed.
To move from OTC to a standard exchange will ALRTF need to show profitability? Is it possible we are not and therefore hesitant to apply?
Disheartening, my third decade owning this dog. i expected some news to give us reason to be excited after launching the pet product. How long do they expect us to hang in here with little to no updates? I’ve lost faith in a little reminder.
We sure could use an update from A Little Reminder. Hopefully tomorrow.
I’m not sure when ALR started, but I bought in in 1999. They launched as a table top pet reminder device. It would alarm to remind pet owners to dispense pet meds. To be more compliant giving meds.
I am a T2 diabetic and haven’t checked my blood in 6 months. Exactly as you described, LOS. I rely on the med and a six month blood work to see how poorly I follow the docs orders i.e. exercise, eating habits and testing. When I practiced proper eating and testing, my A1C was in the 5.5 arena. Now, it’s 6.5 with a bullet. I’ll get back untracked after the holidays, lol.
In 1999, when I bought in, ALR was a table-top reminder for pet parents to remember to dispense their pets meds. It may or may not have been under the name ALR at the time. It seems to me it had a different call sign, but my memory is not always spot on. In any event, these are exciting times and a long time coming for this investor.
bbhogs, what product did they launch with 30+ years ago?
Yeah, cannot speculate what “delays” means. Maybe it’s supply chain issues and/or maybe it’s validation paperwork errors. Pharma cGMPs can be a stickler. In any event, they gave us an update around the date they promised one. Still hopeful here. Not investing more, but still hopeful.
A stronger launch sounds good to me. Let’s put our best foot forward when we finally hit the market. Go ALRT!
“The GluCurve production line is up and running, but our manufacturer has experienced delays before final testing can occur and our completed distribution agreement can be signed. During this time, we will continue to work closely with our planned partner on marketing content, strategy, and execution of the launch.”
Mr. Stern concludes, “We believe this extra time will contribute to a stronger and more successful launch in the coming months. We have universally received fantastic feedback on both the product and its need in the marketplace, and we look forward to providing more updates in the near future.”
Since 1999, when it was a pet med reminder device.
Trying to check my enthusiasm and at the same time checking for updates daily. Within 8 months of retirement and hopeful this will pad my retirement nicely. It’s been an incredibly long haul so I’m wishful for a happy ending here soon. Best wishes to all.
Very much appreciate the information, LOS. You’ve been a rock through all of this. Thank you.
Can a penny stock go to double-digit-dollar stock? I’m not a seasoned/educated investor, but thought this stock is limited by the small number of available stock for purchase.
Just re-read the announcement. We should have more info by July 31st. It’s happening, people!
“The Manufacturing Agreement is subject to certain closing conditions including the completion of a distribution agreement with a third party by July 31, 2022.”
I see opportunity, too! Buy baby, buy!
I bought my shares when it was in the dollar range so it makes sense to grab the knife. Glta!
Stock up, baby!
23 x 750k = about the same as ALRT. And developing software for consumer product companies is way easier route than seeking pharma and FDA approvals. Seeking partnerships takes time as well. I’m ok where we are now. Let’s go ALRT.